ST
AVDL

Spot Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

Spot Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-20,000
Closed -$248K – 2763
2016
Q3 		$248K Hold
20,000
– – 0.01% 1950
2016
Q2 		$215K Buy
+20,000
New +$213K ﹤0.01% 2170

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Spot Trading's AVDL Position: Q4 2016 in Review

Spot Trading sold out of Avadel Pharmaceuticals (AVDL) in Q4 2016, closing a stake of 2,900 shares — an estimated $36K sold.

Spot Trading first reported a position in AVDL in Q2 2016 and held it in 2 quarters. The position peaked at $75K in Q2 2016. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

  • Spot Trading reported no remaining Avadel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 2,900 Avadel Pharmaceuticals shares in Q4 2016, an estimated $36K.
  • Spot Trading first reported a position in Avadel Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Spot Trading's Avadel Pharmaceuticals position peaked at $75K in Q2 2016.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.